Oclaro (Nasdaq: OCLR ) is expected to report Q4 earnings around July 28. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Oclaro's revenues will decrease -3.5% and EPS will remain in the red.
The average estimate for revenue is $105.4 million. On the bottom line, the average EPS estimate is -$0.16.
Last quarter, Oclaro chalked up revenue of $88.7 million. GAAP reported sales were 23% lower than the prior-year quarter's $115.7 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at -$0.31. GAAP EPS were -$0.34 for Q3 against -$0.20 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 15.4%, 920 basis points worse than the prior-year quarter. Operating margin was -19.2%, 1,430 basis points worse than the prior-year quarter. Net margin was -19.3%, 1,080 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $386.4 million. The average EPS estimate is -$1.05.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 125 members out of 156 rating the stock outperform, and 31 members rating it underperform. Among 32 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 27 give Oclaro a green thumbs-up, and five give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Oclaro is hold, with an average price target of $5.83.
Over the decades, small-cap stocks, like Oclaro have provided market-beating returns, provided they're value priced and have solid businesses. Read about a pair of companies with a lock on their markets in "Too Small to Fail: Two Small Caps the Government Won't Let Go Broke." Click here for instant access to this free report.
- Add Oclaro to My Watchlist.